Literature DB >> 25031772

Development of angioimmunoblastic T-cell lymphoma after treatment of diffuse large B-cell lymphoma: a case report and review of literature.

Yaya Wang1, Bailu Xie2, Yu Chen3, Zhenqian Huang1, Huo Tan1.   

Abstract

Cases of diffuse large B-cell lymphoma (DLBCL) arising after the initial diagnosis of angioimmunoblastic T-cell lymphoma (AITL) and DLBCL synchronous with AITL have been reported. To date, there is no report on the subsequent development of AITL in patients with DLBCL. Here we presented a rare case of AITL developing six months after the initial diagnosis of DLBCL. In order to investigate the clinical and molecular features of patients with AITL and DLBCL, we also reviewed the literature on AITL patients developing DLBCL, and patients with composite AITL and DLBCL.

Entities:  

Keywords:  Angioimmunoblastic T-cell lymphoma; composite lymphoma; diffuse large B-cell lymphoma

Mesh:

Year:  2014        PMID: 25031772      PMCID: PMC4097218     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  19 in total

Review 1.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Durable remission after the administration of rituximab for EBV-negative, diffuse large B-cell lymphoma following autologous peripheral blood stem cell transplantation for angioimmunoblastic T-cell lymphoma.

Authors:  Akihito Shinohara; Takashi Asai; Koji Izutsu; Yasunori Ota; Kengo Takeuchi; Akira Hangaishi; Yoshinobu Kanda; Shigeru Chiba; Toru Motokura; Mineo Kurokawa
Journal:  Leuk Lymphoma       Date:  2007-02

3.  Angioimmunoblastic T-cell lymphoma with an evolving Epstein Barr virus-positive diffuse large B-cell lymphoma with unusual clinical and pathologic findings.

Authors:  Rodrigo O B Maegawa; Sajid Hussain; Daniel C Danila; Julie Teruya-Feldstein; Robert G Maki; Owen A O'Connor
Journal:  Leuk Lymphoma       Date:  2007-10

Review 4.  Composite angioimmunoblastic T-cell lymphoma and diffuse large B-cell lymphoma: a case report and review of the literature.

Authors:  Yin Xu; Robert W McKenna; Mai P Hoang; Robert H Collins; Steven H Kroft
Journal:  Am J Clin Pathol       Date:  2002-12       Impact factor: 2.493

5.  Composite lymphoma.

Authors:  H Kim; R Hendrickson; R F Dorfman
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

Review 6.  Composite lymphoma and related disorders.

Authors:  H Kim
Journal:  Am J Clin Pathol       Date:  1993-04       Impact factor: 2.493

7.  Angioimmunoblastic T-cell lymphoma with supervening Epstein-Barr virus-associated large B-cell lymphoma.

Authors:  Robert C Hawley; Milena Cankovic; Richard J Zarbo
Journal:  Arch Pathol Lab Med       Date:  2006-11       Impact factor: 5.534

8.  Histologic evolution of angioimmunoblastic T-cell lymphoma in consecutive biopsies: clinical correlation and insights into natural history and disease progression.

Authors:  Ayoma Deepthi Attygalle; Charalampia Kyriakou; Jehan Dupuis; Karen Lynne Grogg; Timothy Charles Diss; Andrew Charles Wotherspoon; Shih Sung Chuang; José Cabeçadas; Peter Gershon Isaacson; Ming-Qing Du; Philippe Gaulard; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2007-07       Impact factor: 6.394

Review 9.  Second primary lymphoma or recurrence: a dilemma solved by VDJ rearrangement analysis.

Authors:  Massimo Libra; Valli De Re; Annunziata Gloghini; Patrick Michael Navolanic; Antonino Carbone; Mauro Boiocchi
Journal:  Leuk Lymphoma       Date:  2004-08

Review 10.  Epstein-Barr virus-negative, CD5-positive diffuse large B-cell lymphoma developing after treatment with oral tacrolimus for mixed connective tissue disease : a case report and review of the literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomonori Sawada; Norio Komatsu; Masaaki Noguchi
Journal:  J Clin Exp Hematop       Date:  2012
View more
  6 in total

1.  Pathological and molecular analysis of a composite lymphoma of mantle cell lymphoma and Epstein-Barr virus-positive follicular lymphoma.

Authors:  Yuri Miyazawa; Akihiko Yokohama; Takuma Ishizaki; Norifumi Tsukamoto; Hiromi Koshi; Junko Hirato; Hiroshi Handa
Journal:  Int J Hematol       Date:  2021-01-02       Impact factor: 2.490

Review 2.  Neoplasms of follicular helper T-cells: an insight into the pathobiology.

Authors:  Surabhi Jain; Saumyaranjan Mallick; Prashant Ramteke; Ajay Gogia
Journal:  Am J Blood Res       Date:  2022-06-20

3.  Epstein-Barr virus positive diffuse large B-cell lymphoma transformed into angioimmunoblastic T-cell lymphoma after treatment.

Authors:  Chaoyu Wang; Yi Gong; Qingming Jiang; Xiping Liang; Rui Chen
Journal:  Clin Case Rep       Date:  2021-05-05

4.  Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report.

Authors:  Pan Hu; Yu Ben; Juan Liu; Weicheng Zheng; Xiyue Yan; Yaping Zhang; Wenyu Shi
Journal:  Onco Targets Ther       Date:  2021-04-12       Impact factor: 4.147

5.  A preclinical model of peripheral T-cell lymphoma GATA3 reveals DNA damage response pathway vulnerability.

Authors:  Elizabeth A Kuczynski; Giulia Morlino; Alison Peter; Anna M L Coenen-Stass; Jennifer I Moss; Neha Wali; Oona Delpuech; Avinash Reddy; Anisha Solanki; Charles Sinclair; Dinis P Calado; Larissa S Carnevalli
Journal:  EMBO Mol Med       Date:  2022-05-05       Impact factor: 14.260

6.  Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma.

Authors:  Fen Zhang; Wenyu Li; Qian Cui; Yu Chen; Yanhui Liu
Journal:  Front Genet       Date:  2022-07-22       Impact factor: 4.772

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.